GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » Cyclically Adjusted Revenue per Share

Shandong Sito Bio-technology Co (SZSE:300583) Cyclically Adjusted Revenue per Share : ¥6.44 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shandong Sito Bio-technology Co's adjusted revenue per share for the three months ended in Sep. 2024 was ¥1.138. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥6.44 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-12-12), Shandong Sito Bio-technology Co's current stock price is ¥24.10. Shandong Sito Bio-technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was ¥6.44. Shandong Sito Bio-technology Co's Cyclically Adjusted PS Ratio of today is 3.74.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Shandong Sito Bio-technology Co was 4.14. The lowest was 2.97. And the median was 3.84.


Shandong Sito Bio-technology Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Shandong Sito Bio-technology Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co Cyclically Adjusted Revenue per Share Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shandong Sito Bio-technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 6.44

Competitive Comparison of Shandong Sito Bio-technology Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Shandong Sito Bio-technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sito Bio-technology Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Sito Bio-technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Sito Bio-technology Co's Cyclically Adjusted PS Ratio falls into.



Shandong Sito Bio-technology Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Sito Bio-technology Co's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1.138/115.7848*115.7848
=1.138

Current CPI (Sep. 2024) = 115.7848.

Shandong Sito Bio-technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 0.000 95.237 0.000
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201509 0.000 100.500 0.000
201512 1.413 100.600 1.626
201603 0.368 102.200 0.417
201606 1.690 101.400 1.930
201609 0.922 102.400 1.043
201612 1.438 102.600 1.623
201703 0.604 103.200 0.678
201706 1.296 103.100 1.455
201709 1.157 104.100 1.287
201712 1.648 104.500 1.826
201803 1.393 105.300 1.532
201806 1.872 104.900 2.066
201809 1.658 106.600 1.801
201812 1.239 106.500 1.347
201903 1.683 107.700 1.809
201906 1.687 107.700 1.814
201909 1.212 109.800 1.278
201912 1.063 111.200 1.107
202003 1.260 112.300 1.299
202006 1.667 110.400 1.748
202009 1.341 111.700 1.390
202012 1.095 111.500 1.137
202103 1.585 112.662 1.629
202106 2.116 111.769 2.192
202109 1.543 112.215 1.592
202112 1.819 113.108 1.862
202203 1.493 114.335 1.512
202206 2.185 114.558 2.208
202209 1.731 115.339 1.738
202212 2.070 115.116 2.082
202303 1.962 115.116 1.973
202306 3.016 114.558 3.048
202309 1.743 115.339 1.750
202312 1.955 114.781 1.972
202403 1.592 115.227 1.600
202406 1.439 114.781 1.452
202409 1.138 115.785 1.138

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Shandong Sito Bio-technology Co  (SZSE:300583) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shandong Sito Bio-technology Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.10/6.44
=3.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Shandong Sito Bio-technology Co was 4.14. The lowest was 2.97. And the median was 3.84.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shandong Sito Bio-technology Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sito Bio-technology Co Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao County, Shandong Province, Heze, CHN, 274000
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It is specialized in the research and development and production of core derivatives and derivatives of new steroid hormone drugs. The company offers bio-steroidal drug raw materials such as androstenedione, nonhydroxyandrostenedione and androstenedione.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co Headlines

No Headlines